Arca
Skip to content
Tools
Tools

Accell EVO3C

Filler, Bone Void, Osteoinduction (W/O Human Growth Factor). 510(k) K091193, from Isotis Orthobiologics, Inc. (Irvine, CA). Product code MBP, class 2.

As of Nov 18, 2026, K091193 is an FDA 510(k) held by Isotis Orthobiologics, Inc., substantially equivalent on Aug 10, 2009 after 109 days, with 1 recall tied to it in FDA's recall database.

  • Review time: 109 days
  • Recalls: 1
  • Cited as a predicate by: 1 device

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

Accell Evo3c TM is intended for filling voids and gaps in the skeletal system that are not intrinsic to the stability of the bony structure. Accell Evo3c is indicated for use as a bone graft extender in the posterolateral spine, extremities and pelvis, or as a bone void filler in the extremities and pelvis.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Recalls

Recalls FDA ties to K091193, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
StartedRecallStatus
May 19, 2014Z-1868-2014This lot of Accell Evo3C Demineralized Bone Matrix, 5cc was incorrectly packaged in boxes that describe the product as Accell Evo3 Demineralized Bone Matrix. Evo3C is contraindicated for treatment of vertebral…Terminated

Other MBP clearances

The newest 510(k)s for the same product code; see every MBP device
  • PliaFX FloK242799 · Lifenet Health · Nov 21, 2024

Record

Type
Traditional
Received
Apr 23, 2009
Review panel
Orthopedic
Regulation
21 CFR 888.3045

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.